Wird geladen...
Inhibiting TRF1 upstream signaling pathways to target telomeres in cancer cells
In the context of tumorigenesis, telomere shortening is associated with apparent antagonistic outcomes: On one side, it favors cancer initiation through mechanisms involving genome instability, while on the other side, it prevents cancer progression, due to the activation of the DNA damage response...
Gespeichert in:
| Veröffentlicht in: | EMBO Mol Med |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609909/ https://ncbi.nlm.nih.gov/pubmed/31273935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201910845 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|